{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:39:18Z","timestamp":1779907158471,"version":"3.53.1"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA007304"],"award-info":[{"award-number":["DA007304"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA044809"],"award-info":[{"award-number":["DA044809"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 DA007097"],"award-info":[{"award-number":["T32 DA007097"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.brainres.2019.146467","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:05:06Z","timestamp":1568718306000},"page":"146467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder"],"prefix":"10.1016","volume":"1724","author":[{"given":"Mariah M.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Asher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley A.","family":"Thayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2019.146467_b0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/bph.13337","article-title":"Actions of the dual FAAH\/MAGL inhibitor JZL195 in a murine neuropathic pain model","volume":"173","author":"Adamson Barnes","year":"2016","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0010","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.drudis.2014.06.007","article-title":"Harnessing the anti-inflammatory potential of palmitoylethanolamide","volume":"19","author":"Alhouayek","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.brainres.2019.146467_b0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/08820139709022691","article-title":"Cytokine patterns in adults with AIDS","volume":"26","author":"Alonso","year":"1997","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.brainres.2019.146467_b0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","article-title":"Inflammation in neurodegenerative diseases","volume":"129","author":"Amor","year":"2010","journal-title":"Immunology."},{"key":"10.1016\/j.brainres.2019.146467_b0025","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuropharm.2013.12.018","article-title":"Actions of the dual FAAH\/MAGL inhibitor JZL195 in a murine inflammatory pain model","volume":"81","author":"Anderson","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.146467_b0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/157015907780866884","article-title":"The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration","volume":"5","author":"Ashton","year":"2007","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-2012-111862","article-title":"CB1 agonist ACEA protects neurons and reduces the cognitive impairment of AbetaPP\/PS1 mice","volume":"30","author":"Aso","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2019.146467_b0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fphar.2014.00037","article-title":"Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic","volume":"5","author":"Aso","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies","volume":"372","author":"ATCC","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2019.146467_b0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/bph.12478","article-title":"The cannabinoid CB(2) receptor agonist AM1241 enhances neurogenesis in GFAP\/Gp120 transgenic mice displaying deficits in neurogenesis","volume":"171","author":"Avraham","year":"2014","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0055","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1111\/bph.12657","article-title":"Impaired neurogenesis by HIV-1-Gp120 is rescued by genetic deletion of fatty acid amide hydrolase enzyme","volume":"172","author":"Avraham","year":"2015","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-5793(95)01207-U","article-title":"The peripheral cannabinoid receptor \u2013 adenylate cyclase inhibition and g protein coupling","volume":"375","author":"Bayewitch","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.brainres.2019.146467_b0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41398-018-0141-7","article-title":"Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors","volume":"8","author":"Bedse","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.brainres.2019.146467_b0070","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0075","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1523\/JNEUROSCI.3923-04.2005","article-title":"A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis","volume":"25","author":"Benito","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bmcl.2018.11.048","article-title":"Discovery and evaluation of novel FAAH inhibitors in neuropathic pain model","volume":"29","author":"Bhuniya","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.brainres.2019.146467_b0085","doi-asserted-by":"crossref","DOI":"10.1096\/fj.05-4743fje","article-title":"Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice","author":"Bilsland","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2019.146467_b0090","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.brainres.2019.146467_b0095","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/pr.112.006387","article-title":"Chemical probes of endocannabinoid metabolism","volume":"65","author":"Blankman","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.brainres.2019.146467_b0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1476-5381.2010.00787.x","article-title":"Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls","volume":"160","author":"Buczynski","year":"2010","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0090-6980(00)00053-8","article-title":"Oxidative metabolism of anandamide","volume":"61","author":"Burstein","year":"2000","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.brainres.2019.146467_b0110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.biopsych.2011.04.022","article-title":"Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses","volume":"70","author":"Busquets-Garcia","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2019.146467_b0115","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.brainres.2019.146467_b0120","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1124\/mol.65.4.999","article-title":"Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism","volume":"65","author":"Carrier","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0125","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamapediatrics.2016.3624","article-title":"Association of state recreational marijuana laws with adolescent marijuana use","volume":"171","author":"Cerda","year":"2017","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.brainres.2019.146467_b0130","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1124\/mol.110.068304","article-title":"Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system","volume":"78","author":"Chanda","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.bjp.0706699","article-title":"Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms","volume":"148","author":"Chang","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0145","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0896-6273(03)00499-9","article-title":"Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures","volume":"39","author":"Chen","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2019.146467_b0150","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.celrep.2012.09.030","article-title":"Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease","volume":"2","author":"Chen","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.brainres.2019.146467_b0155","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1021\/acs.jmedchem.8b00951","article-title":"Identification of ABX-1431, a selective inhibitor of monoacylglycerol lipase and clinical candidate for treatment of neurological disorders","volume":"61","author":"Cisar","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainres.2019.146467_b0160","doi-asserted-by":"crossref","first-page":"11152","DOI":"10.1038\/s41598-017-11606-1","article-title":"The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity","volume":"7","author":"Colangeli","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2019.146467_b0165","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2990.2011.01177.x","article-title":"Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities","volume":"37","author":"Cosenza-Nashat","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.brainres.2019.146467_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033961","article-title":"Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells","volume":"7","author":"Costantino","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2019.146467_b0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2019.146467_b0180","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1111\/bph.14055","article-title":"The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice","volume":"174","author":"Crowe","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0185","doi-asserted-by":"crossref","DOI":"10.1002\/syn.21984","article-title":"Interleukin 6 trans-signaling regulates basal synaptic transmission and sensitivity to pentylenetetrazole-induced seizures in mice","volume":"71","author":"Cuevas-Olguin","year":"2017","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2019.146467_b0190","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/13550280490521078","article-title":"Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus\u2013infected\/acquired immunodeficiency syndrome (HIV\/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts","volume":"10","author":"Cysique","year":"2004","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.brainres.2019.146467_b0195","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1111\/j.1476-5381.2011.01455.x","article-title":"Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine\/threonine kinases to activate ERK in neuronal cells","volume":"165","author":"Dalton","year":"2012","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0200","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.neuropharm.2012.01.030","article-title":"Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects","volume":"62","author":"de Lago","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.146467_b0205","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.brainres.2019.146467_b0210","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(98)01283-1","article-title":"Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action [Review]","volume":"21","author":"Di Marzo","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0215","first-page":"1","article-title":"Endocannabinoids: synthesis and degradation","volume":"160","author":"Di Marzo","year":"2008","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0220","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn3876","article-title":"Endocannabinoid signalling and the deteriorating brain","volume":"16","author":"Di Marzo","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0225","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.brainres.2019.146467_b0230","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1097\/00002030-200307040-00015","article-title":"Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy","volume":"17","author":"Dore","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.brainres.2019.146467_b0235","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0306-4522(03)00145-3","article-title":"Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling","volume":"119","author":"Egertova","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2019.146467_b0240","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/cne.21568","article-title":"Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: a new perspective on N-acylethanolamines as neural signaling molecules","volume":"506","author":"Egertova","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2019.146467_b0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-2-29","article-title":"Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation","volume":"2","author":"Ehrhart","year":"2005","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.brainres.2019.146467_b0250","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/13550280903131915","article-title":"Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy","volume":"15","author":"Everall","year":"2009","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.brainres.2019.146467_b0255","article-title":"Plants come to mind: phytocannabinoids, endocannabinoids and the control of seizures","author":"Farrell","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.brainres.2019.146467_b0260","doi-asserted-by":"crossref","first-page":"21931","DOI":"10.1038\/srep21931","article-title":"Transient increase of interleukin-1beta after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling","volume":"6","author":"Feng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2019.146467_b0265","doi-asserted-by":"crossref","first-page":"10550","DOI":"10.1523\/JNEUROSCI.4403-14.2015","article-title":"Induction of interleukin-1beta by human immunodeficiency virus-1 viral proteins leads to increased levels of neuronal ferritin heavy chain, synaptic injury, and deficits in flexible attention","volume":"35","author":"Festa","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0270","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s11481-011-9291-6","article-title":"Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat","volume":"6","author":"Fraga","year":"2011","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0275","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.brainres.2019.146467_b0280","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pnpbp.2010.11.027","article-title":"Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice","volume":"35","author":"Gomes","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2019.146467_b0285","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.146467_b0290","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0026-895X(24)26516-0","article-title":"Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide","volume":"57","author":"Gonsiorek","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0295","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11481-010-9225-8","article-title":"Immunoregulation of a CB2 receptor agonist in a murine Model of NeuroAIDS","volume":"5","author":"Gorantla","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0300","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2017.02.033","article-title":"Monoglyceride lipase as a drug target: at the crossroads of arachidonic acid metabolism and endocannabinoid signaling","volume":"175","author":"Grabner","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2019.146467_b0305","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/13543776.2018.1389899","article-title":"A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013\u20132017)","volume":"27","author":"Granchi","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.brainres.2019.146467_b0310","article-title":"Scaling synapses in the presence of HIV","author":"Green","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2019.146467_b0315","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/nn.2685","article-title":"Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens","volume":"13","author":"Grueter","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015707","article-title":"AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity","volume":"5","author":"Guggenhuber","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2019.146467_b0325","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000338494","article-title":"CB1 cannabinoid receptor activation rescues amyloid beta-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones","volume":"29","author":"Haghani","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.brainres.2019.146467_b0330","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1021\/acsmedchemlett.7b00396","article-title":"Discovery of APD371: identification of a highly potent and selective CB2 agonist for the treatment of chronic pain","volume":"8","author":"Han","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.brainres.2019.146467_b0335","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00213-005-2242-2","article-title":"Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood","volume":"181","author":"Haney","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2019.146467_b0340","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1021\/jm00072a026","article-title":"Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor","volume":"36","author":"Hanus","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainres.2019.146467_b0345","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.061029898","article-title":"2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor","volume":"98","author":"Hanus","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.brainres.2019.146467_b0350","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1017\/S1355617700000230","article-title":"The HNRC 500\u2013neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center","volume":"1","author":"Heaton","year":"1995","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.brainres.2019.146467_b0355","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2019.146467_b0360","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.physiol.010908.163149","article-title":"Endocannabinoid signaling and long-term synaptic plasticity","volume":"71","author":"Heifets","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.brainres.2019.146467_b0365","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0370","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuropharm.2018.08.013","article-title":"Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS","volume":"141","author":"Hermes","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.146467_b0375","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors [Review]","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.brainres.2019.146467_b0380","article-title":"CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120","volume":"8","author":"Hu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2019.146467_b0385","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","volume":"153","author":"Huggins","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.brainres.2019.146467_b0390","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.bmcl.2016.06.076","article-title":"Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders","volume":"26","author":"Janssen","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.brainres.2019.146467_b0395","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fnins.2016.00321","article-title":"Cannabinoid type 2 (CB2) receptors activation protects against oxidative stress and neuroinflammation associated dopaminergic neurodegeneration in rotenone model of Parkinson's disease","volume":"10","author":"Javed","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0400","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pbb.2015.11.006","article-title":"Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer's disease","volume":"140","author":"Jayant","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2019.146467_b0405","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918814345","article-title":"Analgesic effects of FAAH inhibitor in the insular cortex of nerve-injured rats","volume":"14","author":"Jee Kim","year":"2018","journal-title":"Mol. Pain"},{"key":"10.1016\/j.brainres.2019.146467_b0410","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2334\/josnusd.17-0005","article-title":"Inhibition of 2-arachydonoylgycerol degradation attenuates orofacial neuropathic pain in trigeminal nerve-injured mice","volume":"60","author":"Kamimura","year":"2018","journal-title":"J. Oral Sci."},{"key":"10.1016\/j.brainres.2019.146467_b0415","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.brainres.2019.146467_b0420","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2183\/pjab.90.235","article-title":"Control of synaptic function by endocannabinoid-mediated retrograde signaling","volume":"90","author":"Kano","year":"2014","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.brainres.2019.146467_b0425","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1124\/jpet.107.120147","article-title":"Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage","volume":"322","author":"Karanian","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2019.146467_b0430","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJMoa1604221","article-title":"Acute neurologic disorder from an inhibitor of fatty acid amide hydrolase","volume":"375","author":"Kerbrat","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2019.146467_b0435","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/mol.111.071647","article-title":"Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss","volume":"80","author":"Kim","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0440","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.109.155465","article-title":"Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain","volume":"330","author":"Kinsey","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2019.146467_b0445","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.pbb.2011.06.022","article-title":"Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice","volume":"99","author":"Kinsey","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2019.146467_b0450","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pbb.2010.12.002","article-title":"Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay","volume":"98","author":"Kinsey","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2019.146467_b0455","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjp.0705304","article-title":"Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor","volume":"139","author":"Klegeris","year":"2003","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0460","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1476-5381.2011.01379.x","article-title":"Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL\/6 mice","volume":"163","author":"Kozela","year":"2011","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0465","first-page":"CD007204","article-title":"Cannabinoids for the treatment of dementia","author":"Krishnan","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.brainres.2019.146467_b0470","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.neuropharm.2012.07.014","article-title":"Epileptic stimulus increases Homer 1a expression to modulate endocannabinoid signaling in cultured hippocampal neurons","volume":"63","author":"Li","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.146467_b0475","doi-asserted-by":"crossref","first-page":"13345","DOI":"10.1073\/pnas.0601832103","article-title":"A biosynthetic pathway for anandamide","volume":"103","author":"Liu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2019.146467_b0480","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugalcdep.2010.11.004","article-title":"Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"115","author":"Lopez-Quintero","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainres.2019.146467_b0485","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuroscience.2010.10.062","article-title":"Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus","volume":"174","author":"Ludanyi","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2019.146467_b0490","first-page":"CD005175","article-title":"The medical use of cannabis for reducing morbidity and mortality in patients with HIV\/AIDS","volume":"4","author":"Lutge","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.brainres.2019.146467_b0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114521","article-title":"Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome","volume":"9","author":"Lysenko","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2019.146467_b0500","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0026-895X(25)13215-X","article-title":"Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells","volume":"44","author":"Mackie","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0505","series-title":"Cannabinoids","first-page":"299","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","author":"Mackie","year":"2005"},{"key":"10.1016\/j.brainres.2019.146467_b0510","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/130639","article-title":"Anandamide, Acting via CB2 receptors, alleviates LPS-induced neuroinflammation in rat primary microglial cultures","volume":"2015","author":"Malek","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.brainres.2019.146467_b0515","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuropharm.2018.08.038","article-title":"Re-examining the potential of targeting ABHD6 in multiple sclerosis: efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis","volume":"141","author":"Manterola","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.146467_b0520","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nn.2601","article-title":"The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors","volume":"13","author":"Marrs","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0525","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0530","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.brainres.2019.146467_b0535","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/cne.903270406","article-title":"Localization of cannabinoid receptor mRNA in rat brain","volume":"327","author":"Matsuda","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2019.146467_b0540","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.43.11.2230","article-title":"Clinical-neuropathologic correlation in HIV-associated dementia","volume":"43","author":"McArthur","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2019.146467_b0545","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","article-title":"Endocannabinoids drive the acquisition of an alternative phenotype in microglia","volume":"49","author":"Mecha","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2019.146467_b0550","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0555","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/nn.4428","article-title":"Astrocytes mediate neurovascular signaling to capillary pericytes but not to arterioles","volume":"19","author":"Mishra","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0560","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1440-1681.2007.04692.x","article-title":"Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models","volume":"34","author":"Mitchell","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.brainres.2019.146467_b0565","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1523\/JNEUROSCI.22-22-09742.2002","article-title":"Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase\/Akt signaling","volume":"22","author":"Molina-Holgado","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0570","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1523\/JNEUROSCI.23-16-06470.2003","article-title":"Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia","volume":"23","author":"Molina-Holgado","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0575","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbrc.2016.12.115","article-title":"Computational proteome-wide screening predicts neurotoxic drug-protein interactome for the investigational analgesic BIA 10\u20132474","volume":"483","author":"Molinski","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2019.146467_b0580","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2019.146467_b0585","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13024-015-0012-0","article-title":"Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection","volume":"10","author":"More","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.brainres.2019.146467_b0590","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.expneurol.2015.07.024","article-title":"Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"273","author":"Mounsey","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2019.146467_b0595","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1523\/JNEUROSCI.4830-06.2007","article-title":"Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells","volume":"27","author":"Muccioli","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0600","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1523\/JNEUROSCI.19-08-02987.1999","article-title":"Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures","volume":"19","author":"Nagayama","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0605","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s13311-011-0100-y","article-title":"Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase \u2013 dual targets of the endocannabinoid system to protect against seizure pathology","volume":"9","author":"Naidoo","year":"2012","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.brainres.2019.146467_b0610","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuropharm.2014.11.024","article-title":"Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy","volume":"95","author":"Nasirinezhad","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.146467_b0615","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2008.01.029","article-title":"Endocannabinoids mediate neuron-astrocyte communication","volume":"57","author":"Navarrete","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2019.146467_b0620","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuron.2010.08.043","article-title":"Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes","volume":"68","author":"Navarrete","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2019.146467_b0625","doi-asserted-by":"crossref","first-page":"20130599","DOI":"10.1098\/rstb.2013.0599","article-title":"Astrocytes in endocannabinoid signalling","volume":"369","author":"Navarrete","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.brainres.2019.146467_b0630","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neuron.2014.06.030","article-title":"ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6\/2 mice","volume":"83","author":"Naydenov","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2019.146467_b0635","article-title":"Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model","author":"Naziroglu","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.brainres.2019.146467_b0640","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.brainres.2019.146467_b0645","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/syn.20050","article-title":"Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study","volume":"53","author":"Nunez","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2019.146467_b0650","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1073858410397377","article-title":"Endocannabinoids and retrograde modulation of synaptic transmission","volume":"18","author":"Ohno-Shosaku","year":"2012","journal-title":"Neuroscientist"},{"key":"10.1016\/j.brainres.2019.146467_b0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2014.03.017","article-title":"Endocannabinoid-mediated retrograde modulation of synaptic transmission","volume":"29C","author":"Ohno-Shosaku","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.brainres.2019.146467_b0660","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.1074\/jbc.M413260200","article-title":"Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear","volume":"280","author":"Oka","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2019.146467_b0665","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.4049\/jimmunol.177.12.8796","article-title":"Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice","volume":"177","author":"Oka","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.brainres.2019.146467_b0670","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1080\/00952990.2016.1245738","article-title":"Prevalence and correlates of marijuana use among HIV-seropositive and seronegative men in the Multicenter AIDS Cohort Study (MACS), 1984\u20132013","volume":"43","author":"Okafor","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.brainres.2019.146467_b0675","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuroscience.2015.05.002","article-title":"Astroglial type-1 cannabinoid receptor (CB1): a new player in the tripartite synapse","volume":"323","author":"Oliveira da Cruz","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2019.146467_b0680","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1521\/aeap.2018.30.2.169","article-title":"Frequency of cannabis use and medical cannabis use among persons living With HIV in the United States: findings from a nationally representative sample","volume":"30","author":"Pacek","year":"2018","journal-title":"AIDS Educ. Prev."},{"key":"10.1016\/j.brainres.2019.146467_b0685","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awp239","article-title":"Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity","author":"Palazuelos","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2019.146467_b0690","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/35097089","article-title":"An endogenous cannabinoid (2-AG) is neuroprotective after brain injury","volume":"413","author":"Panikashvili","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2019.146467_b0695","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/cmdc.201402453","article-title":"Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors","volume":"10","author":"Patel","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.brainres.2019.146467_b0700","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2)","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.brainres.2019.146467_b0705","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12974-015-0305-9","article-title":"Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells","volume":"12","author":"Pihlaja","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.brainres.2019.146467_b0710","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.celrep.2012.05.001","article-title":"A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease","volume":"1","author":"Piro","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.brainres.2019.146467_b0715","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0091-3057(91)90385-F","article-title":"Recent clinical experience with dronabinol","volume":"40","author":"Plasse","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"Suppl. 1","key":"10.1016\/j.brainres.2019.146467_b0720","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/dom.13008","article-title":"Monoacylglycerol signalling and ABHD6 in health and disease","volume":"19","author":"Poursharifi","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.brainres.2019.146467_b0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cobeha.2016.07.001","article-title":"Cognitive motor deficits in cannabis users","volume":"13","author":"Prashad","year":"2017","journal-title":"Curr. Opin. Behav. Sci."},{"key":"10.1016\/j.brainres.2019.146467_b0730","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11481-014-9554-0","article-title":"Cannabinoid receptor-2 and HIV-associated neurocognitive disorders","volume":"9","author":"Purohit","year":"2014","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0735","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.lfs.2014.04.008","article-title":"Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins","volume":"104","author":"Raborn","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2019.146467_b0740","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ramirez","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0745","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","article-title":"The acute effects of cannabinoids on memory in humans: a review","volume":"188","author":"Ranganathan","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2019.146467_b0750","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1744-8069-5-25","article-title":"Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation","volume":"5","author":"Romero-Sandoval","year":"2009","journal-title":"Mol Pain."},{"key":"10.1016\/j.brainres.2019.146467_b0755","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.bjp.0705467","article-title":"Anandamide and vanilloid TRPV1 receptors","volume":"140","author":"Ross","year":"2003","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0760","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.107.119941","article-title":"The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice","volume":"322","author":"Russo","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2019.146467_b0765","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.57.3.542","article-title":"CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing","volume":"57","author":"Sacktor","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2019.146467_b0770","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/nmo.12563","article-title":"The effect of FAAH, MAGL, and Dual FAAH\/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents","volume":"27","author":"Sakin","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.brainres.2019.146467_b0775","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5152\/tjg.2018.18401","article-title":"Dual FAAH and MAGL inhibition might play a key role in visceral pain","volume":"29","author":"Sakin","year":"2018","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.brainres.2019.146467_b0780","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12974-018-1362-7","article-title":"Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells","volume":"15","author":"Saliba","year":"2018","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.brainres.2019.146467_b0785","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.bjp.0704297","article-title":"Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor-dependent G-protein activation in rat cerebellar membranes","volume":"134","author":"Savinainen","year":"2001","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0790","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1748-1716.2011.02280.x","article-title":"The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors","volume":"204","author":"Savinainen","year":"2012","journal-title":"Acta Physiol. (Oxf)."},{"key":"10.1016\/j.brainres.2019.146467_b0795","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder \u2013 pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2019.146467_b0800","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1208\/s12248-008-9075-y","article-title":"Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation","volume":"11","author":"Schlosburg","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.brainres.2019.146467_b0805","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0810","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.phrs.2011.04.010","article-title":"Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats","volume":"64","author":"Sciolino","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.brainres.2019.146467_b0815","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1476-5381.2010.00773.x","article-title":"Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease","volume":"160","author":"Scotter","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0820","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pbb.2014.05.022","article-title":"The dual FAAH\/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184","volume":"124","author":"Seillier","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2019.146467_b0825","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/cns.12349","article-title":"Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome","volume":"20","author":"Shao","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.brainres.2019.146467_b0830","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1523\/JNEUROSCI.16-14-04322.1996","article-title":"Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures","volume":"16","author":"Shen","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b0835","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/mol.54.3.459","article-title":"Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity","volume":"54","author":"Shen","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0840","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/bbrc.2000.2897","article-title":"Activation of NADPH oxidase in Alzheimer's disease brains","volume":"273","author":"Shimohama","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2019.146467_b0845","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1471-4159.2006.04346.x","article-title":"The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset","volume":"101","author":"Shoemaker","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2019.146467_b0850","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0026-895X(25)10254-X","article-title":"Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase","volume":"48","author":"Slipetz","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0855","article-title":"Astrocytic endocannabinoids mediate hippocampal transient heterosynaptic depression","author":"Smith","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2019.146467_b0860","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s00018-008-8006-5","article-title":"G protein betagamma subunits: central mediators of G protein-coupled receptor signaling","volume":"65","author":"Smrcka","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.brainres.2019.146467_b0865","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yebeh.2019.01.033","article-title":"Prevalence and incidence of new-onset seizures and epilepsy in patients with human immunodeficiency virus (HIV): systematic review and meta-analysis","volume":"93","author":"Ssentongo","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.brainres.2019.146467_b0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2016.06.083","article-title":"Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures","author":"Sugaya","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.brainres.2019.146467_b0875","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1074\/jbc.274.5.2794","article-title":"Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds","volume":"274","author":"Sugiura","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2019.146467_b0880","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1074\/jbc.275.1.605","article-title":"Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor \u2013 comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells","volume":"275","author":"Sugiura","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2019.146467_b0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2006.03.003","article-title":"Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand","author":"Sugiura","year":"2006","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.brainres.2019.146467_b0890","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/neu.2012.2647","article-title":"Selective inhibition of alpha\/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury","volume":"30","author":"Tchantchou","year":"2013","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.brainres.2019.146467_b0895","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neuropharm.2014.06.006","article-title":"The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury","volume":"85","author":"Tchantchou","year":"2014","journal-title":"Neuropharmacology"},{"issue":"421","key":"10.1016\/j.brainres.2019.146467_b0900","first-page":"e1","article-title":"Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine","volume":"33","author":"Ternianov","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2019.146467_b0905","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/BF00169393","article-title":"Inhibition of long-term potentiation in rat hippocampal slices by anandamide and win55212-2 - reversal by sr141716 a, a selective antagonist of cb1 cannabinoid receptors","volume":"352","author":"Terranova","year":"1995","journal-title":"Naunyn Schmiedebergs Archiv. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b0910","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/epi.13950","article-title":"Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet","volume":"59","author":"Terrone","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainres.2019.146467_b0915","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1080\/09540121.2015.1124983","article-title":"Combined effects of HIV and marijuana use on neurocognitive functioning and immune status","volume":"28","author":"Thames","year":"2016","journal-title":"AIDS Care"},{"key":"10.1016\/j.brainres.2019.146467_b0920","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1089\/aid.2005.21.706","article-title":"Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART","volume":"21","author":"Tozzi","year":"2005","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.brainres.2019.146467_b0925","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2019.146467_b0930","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(98)00700-9","article-title":"Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry","volume":"254","author":"Tsou","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2019.146467_b0935","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/QAD.0000000000001503","article-title":"Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients","volume":"31","author":"Ubaida-Mohien","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.brainres.2019.146467_b0940","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11904-010-0070-4","article-title":"Pathogenesis of HIV in the central nervous system","volume":"8","author":"Valcour","year":"2011","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.brainres.2019.146467_b0945","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aaf7497","article-title":"Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10\u20132474","volume":"356","author":"van Esbroeck","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.brainres.2019.146467_b0950","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1016\/j.neurobiolaging.2015.08.003","article-title":"Endocannabinoid regulation of amyloid-induced neuroinflammation","volume":"36","author":"Vazquez","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2019.146467_b0955","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2015.04.005","article-title":"Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: in vivo studies","volume":"79","author":"Vazquez","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2019.146467_b0960","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.celrep.2015.06.075","article-title":"Metabolic interplay between astrocytes and neurons regulates endocannabinoid action","volume":"12","author":"Viader","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.brainres.2019.146467_b0965","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12345","article-title":"A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation","volume":"5","author":"Viader","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.brainres.2019.146467_b0970","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2019.146467_b0975","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.nbd.2015.03.016","article-title":"Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice","volume":"77","author":"von Ruden","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2019.146467_b0980","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nbd.2014.08.001","article-title":"Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm","volume":"73","author":"von Ruden","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2019.146467_b0985","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer's disease: causes and clinical relevance","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2019.146467_b0990","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-4690-11-35","article-title":"Rapid inflammasome activation in microglia contributes to brain disease in HIV\/AIDS","volume":"11","author":"Walsh","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.brainres.2019.146467_b0995","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","article-title":"Nonpsychotropic cannabinoid receptors regulate microglial cell migration","volume":"23","author":"Walter","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b1000","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjp.0705667","article-title":"Cannabinoids and neuroinflammation [Review]","volume":"141","author":"Walter","year":"2004","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b1005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12974-016-0786-1","article-title":"Inflammation in epileptogenesis after traumatic brain injury","volume":"14","author":"Webster","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.brainres.2019.146467_b1010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2015.07.010","article-title":"Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis","volume":"99","author":"Wen","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.146467_b1015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12974-017-1045-9","article-title":"WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms","volume":"15","author":"Wen","year":"2018","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.brainres.2019.146467_b1020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0306-4522(94)90511-8","article-title":"Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains","volume":"63","author":"Westlake","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2019.146467_b1025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bjp.0706157","article-title":"CB1 cannabinoid receptor-mediated modulation of food intake in mice","volume":"145","author":"Wiley","year":"2005","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b1030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11481-014-9527-3","article-title":"Delta(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection","volume":"9","author":"Williams","year":"2014","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.brainres.2019.146467_b1035","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1021\/cn200130s","article-title":"Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice","volume":"3","author":"Wise","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b1040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2017.06.015","article-title":"The cannabinoid system and pain","volume":"124","author":"Woodhams","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.146467_b1045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mcn.2017.07.003","article-title":"Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein","volume":"83","author":"Xu","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.brainres.2019.146467_b1050","doi-asserted-by":"crossref","first-page":"22429","DOI":"10.1038\/srep22429","article-title":"NO2 inhalation promotes Alzheimer's disease-like progression: cyclooxygenase-2-derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medication","volume":"6","author":"Yan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2019.146467_b1055","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jnc.12263","article-title":"IL-1beta and TNF-alpha induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase","volume":"125","author":"Ye","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2019.146467_b1060","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1750-3639.2011.00477.x","article-title":"Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D\u2013evidence for altered expression in multiple sclerosis","volume":"21","author":"Zhang","year":"2011","journal-title":"Brain Pathol."},{"key":"10.1016\/j.brainres.2019.146467_b1065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuropharm.2017.10.023","article-title":"Monoacylglycerol lipase inhibitor JZL184 prevents HIV-1 gp120-induced synapse loss by altering endocannabinoid signaling","volume":"128","author":"Zhang","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.146467_b1070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/ph5050529","article-title":"Cannabidiol in humans-the quest for therapeutic targets","volume":"5","author":"Zhornitsky","year":"2012","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319305219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319305219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:09:26Z","timestamp":1777399766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899319305219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":213,"alternative-id":["S0006899319305219"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2019.146467","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2019.146467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146467"}}